| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |